Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2001
10/10/2001EP1140996A2 Type iii secretion system antigens from bordetella pertussis
10/10/2001EP1140989A1 Alpha(v) beta(6) integrin inhibitors
10/10/2001EP1140970A1 47 human secreted proteins
10/10/2001EP1140969A1 Connective tissue growth factor fragments and methods and uses thereof
10/10/2001EP1140964A2 Connective tissue growth factor fragments and methods and uses thereof
10/10/2001EP1140939A1 Substituted 2-aryl-3-(heteroaryl)-imidazo[1,2-alpha]pyrimidines, and related pharmaceutical compositions and methods
10/10/2001EP1140924A1 Piperazine derivatives
10/10/2001EP1140923A1 Method for preparing (r)- (+) -3 1- 2-( 4-benzoyl- 2-(3,4- difluorophenyl)morpholin- 2-yl)ethyl]- 4-phenylpiperidin -4-yl -1,1- dimethylurea, its salts solvates and/or hydrates
10/10/2001EP1140914A1 Non-peptide nk1 receptors antagonists
10/10/2001EP1140895A2 Thiopyran compounds as inhibitors of mmp
10/10/2001EP1140873A1 Il-5 inhibiting 6-azauracil derivatives
10/10/2001EP1140860A1 Pyrimidine compounds
10/10/2001EP1140835A1 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
10/10/2001EP1140828A1 3-azabicyclo[3.1.0]hexane derivatives as opiate receptors ligands
10/10/2001EP1140822A1 Stable activated novel carbamic acid derivatives, preparation method and use for preparing urea
10/10/2001EP1140814A2 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/10/2001EP1140784A2 Ion channel modulating agents
10/10/2001EP1140783A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp
10/10/2001EP1140208A1 Pharmaceutical compositions comprising immortalised endothelial cells
10/10/2001EP1140176A1 Transcutaneous photodynamic treatment of targeted cells
10/10/2001EP1140174A1 Agonists or antagonists of cutaneous t cell-attracting chemokine (ctack) or vasoactive intestinal contractor (vic) chemokines
10/10/2001EP1140170A1 Novel agents and methods for treatment and diagnosis of ocular disorders
10/10/2001EP1140169A2 Methods and compositions for decreasing allergic reactions to surface allergens
10/10/2001EP1140166A2 Novel adjuvant for subunit or component vaccines
10/10/2001EP1140165A1 Improved saponin adjuvant compositions and methods relating thereto
10/10/2001EP1140162A2 Vaccination method for efficient induction of cytotoxic t lymphocyte response
10/10/2001EP1140159A1 Oral vaccine against diarrhea
10/10/2001EP1140153A2 Improvement of tolerance to a xenograft
10/10/2001EP1140152A1 Method to produce inactivated w/o emulsion adjuvated vaccines
10/10/2001EP1140149A1 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells
10/10/2001EP1140141A2 Methods for treating cancer and for mediating chemotaxis of dendritic cells
10/10/2001EP1140138A2 Therapeutic applications of flint polypeptides
10/10/2001EP1140120A2 Human brainiac-5
10/10/2001EP1140118A1 Cyclic adenosine diphosphate ribose analogues for modulating t cell activity
10/10/2001EP1140116A1 Use of adenosine agonists in cancer therapy
10/10/2001EP1140112A1 Use of etherlysophospholipids as antiinflammatory agents
10/10/2001EP1140098A2 Tricyclic nitrogen heterocycles as pde iv inhibitors
10/10/2001EP1140091A2 Formulations comprising imiquimod or other immune response modifiers for treating mucosal consitions
10/10/2001EP1140083A1 Novel compounds
10/10/2001EP1140077A2 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
10/10/2001EP1140052A2 Sensitizing agents for the treatment of skin lesions
10/10/2001EP1140048A2 Methods for treating certain diseases using naaladase inhibitors
10/10/2001EP1140046A1 Use of a mek inhibitor for preventing transplant rejection
10/10/2001EP1140027A1 Dosage forms comprising porous particles
10/10/2001EP1140020A1 Large molecule drug delivery system using aerosolized membrane-mimetic amphiphiles
10/10/2001EP1139980A1 Cosmetic or medical preparation for topical use
10/10/2001EP1139913A1 Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents
10/10/2001EP1139744A1 Exo-r-mecamylamine formulation and use in treatment
10/10/2001EP1139743A1 Exo-s-mecamylamine formulation and use in treatment
10/10/2001EP1083172A4 N-substituted derivatives of 5-oxyiminobarbituric acid
10/10/2001EP0840620B1 Il-8 antagonists for treatment of asthma
10/10/2001EP0765320B1 Benzimidazolone derivatives with central dopaminergic activity
10/10/2001EP0764163B1 Tachykinin (nk 1) receptor antagonists
10/10/2001CN1317013A Peptide fragments of cholera toxic B or enterotoxin B as vaccine adjuvants
10/10/2001CN1316997A Tripterygium wilfordii lactone prodrugs having high aqueous solubility
10/10/2001CN1316995A Hydroxy 2-pipecolate hydroxamide acid derivatives as MMP inhititors
10/10/2001CN1316993A 4,4-biarylpiperidime derivatives with opioid receptor activity
10/10/2001CN1316991A Azetidine derivatives, preparation and medicines containing them
10/10/2001CN1316910A Composition and methods for regulating lymphocyte activation
10/10/2001CN1316901A The use of fumaric acid derivatives in transplant medicine
10/10/2001CN1316432A Cell death inhibitory albumen
10/10/2001CN1316419A Arenesulfonyl amino-iso hydroximic acid derivative
10/10/2001CN1316256A Health-preserving ginseng capsule and its preparing process
10/10/2001CN1072666C (Azetidin-1-ylalkyl) lactams as tachykinin antagonists
10/10/2001CN1072664C Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compound
10/09/2001US6300376 Indane dimer compounds and their pharmaceutical use
10/09/2001US6300372 3-Cyano-3-(3,4-disubstituted) phenylcyclohexyl-1-carboxylates
10/09/2001US6300352 For therapy of asthma
10/09/2001US6300347 For therapy of tumor necrosis factor and interleukin-1 mediated diseases such as rheumatoid arthritis and diseases of bone metabolism, e.g. osteoporosis
10/09/2001US6300341 2-substituted heterocyclic sulfonamides
10/09/2001US6300334 Thieno[2,3-d]pyrimidine-2,4-diones
10/09/2001US6300104 Producing large quantities of secretory immunoglobulin a molecules by transfecting a single cell type with an immunoglobulin containing a polynucleotide encoding a secretory component; collecting, purifying supernatant
10/09/2001US6299888 Azelastine hydrochloride-containing percutaneous preparation having good percutaneous absorbability and reduced skin irritation
10/09/2001US6299884 Administering antigen to animal inpresence of an immunostimulating amount of an adjuvant formulation consisting of metabolizabel oil and emulsifier for increasing immune response to antigen
10/09/2001US6299883 Tarf
10/09/2001US6299882 UL54.5 of Marek's disease virus (MDV)
10/09/2001US6299881 Mixing uronium salt reagent with soluble first moiety selected from polysaccharides and carbohydrates, mixing second moiety with first moiety, wherein second moiety is selected from proteins, peptides, lipoproteins, haptens, carbohydrates
10/09/2001US6299878 Immunosuppressing mammal; administering pooled transferrin-derived glycans from mammal which are free of transferrin polypeptide moieties; grafting foreign cells or tissues to controll immune response
10/09/2001US6299877 Used in therapy
10/09/2001US6299875 Methods to block IGE binding to cell surface receptors of mast cells
10/09/2001US6299874 Administering vaccine conjugate consisting essentially of a live virus and a neutralizing factor bound to live virus; neutralizing factor is selected from the group consisting of antibodies and antibody fragments
10/09/2001US6299869 Human interferon-epsilon: a type I interferon
10/09/2001CA2222296C Peptide and method of obtaining it
10/09/2001CA2218306C Method of preventing allograft rejection
10/09/2001CA2202057C 5-lipoxygenase inhibitors
10/09/2001CA2193224C Chinese herbs extract
10/07/2001CA2340936A1 Inhibitors for the formation of soluble human cd23
10/07/2001CA2304906A1 13-hode, a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
10/07/2001CA2304869A1 Method of medical treatment using uric acid or precursors thereof
10/04/2001WO2001073104A1 Beta-glucans from filamentous fungi
10/04/2001WO2001073078A1 A nucleic acid construct encoding a processing component derived from the n-terminal region of the hepatitis virus orf2, and an antigenic polypeptide
10/04/2001WO2001073035A1 A METHOD FOR SCREENING FOR AUTOIMMUNE DISEASE BY IDENTIFYING POLYMORPHISMS IN IL-12 p40
10/04/2001WO2001073034A2 Beta-like glycoprotein hormone polypeptide and heterodimer
10/04/2001WO2001073032A2 Compositions and methods for the therapy and diagnosis of prostate cancer
10/04/2001WO2001073018A2 Human tap-like protein (transporter associated in antigen processing/presentation)
10/04/2001WO2001072960A2 Il-8 receptor antagonists
10/04/2001WO2001072845A1 Use of cd25 binding molecules in the treatment of inflammatory diseases of the gastro-intestinal tract
10/04/2001WO2001072836A2 G-protein coupled receptors
10/04/2001WO2001072831A2 Immunoregulator
10/04/2001WO2001072830A2 Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using a specific chemokine receptor analysis and the chemokine receptor-ligand interaction
1 ... 857 858 859 860 861 862 863 864 865 866 867 868 869 870 871 872 873 874 875 876 877 ... 1172